| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Singer Nicholas Jason is a Director at Ernexa Therapeutics Inc.. Recent SEC Form 4 filings include 2 buys and 0 sells.
Estimated insider holdings value: $953K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 2, 2022 | ERNA Ernexa Therapeutics Inc. | Director | Buy | 283,286 | $3.28 | $929,178.08 | +270.4% | +13.6% | -63.0% |